EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

New Antibiotics for Treating Infections Caused by Multidrug-Resistant Bacteria

Elisabete Machado iD, João Carlos Sousa

Antibiotics · 05.10.2025 · 14 (10) · 997

DOI: 10.3390/antibiotics14100997 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antibiotics, online erschienen am 05.10.2025. Verfasst von Elisabete Machado und 1 weiteren Autor:innen. Beteiligte Einrichtung: UCIBIO-Applied Molecular Biosciences Unit, Laboratory of Microbiology, Department of Biological Sciences, REQUIMTE, Faculty of Pharmacy, University o…. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Infections caused by antibiotic resistant bacteria pose a serious threat to global health, leading to higher medical costs, longer hospital stays, and increased morbidity and mortality. An increasing number of bacteria have been implicated in untreatable infections due to multiple resistance mechanisms. In 2017, the World Health Organization published a list of the most important antibiotic resistant bacteria worldwide, for which there is an urgent need to develop new therapeutic options. In recent years, fortunately, new antibiotics have been approved for the treatment of infections caused by multidrug-resistant bacteria. The purpose of this review is to present the most impactful new antibiotics that are currently available for the treatment of these infections. The discovery of new therapeutic strategies will help to limit the spread of multidrug-resistant bacteria, but careful prescribing, appropriate use and monitoring of resistant strains will be crucial to ensure that they remain effective in the future.

Schlagwörter

Stichwörter der Autor:innen

MRSAcarbapenem-resistant Acinetobacter baumanniicarbapenem-resistant Enterobacteralescarbapenem-resistant Pseudomonas aeruginosacarbapenemasespre-XDR Mycobacterium tuberculosisβ-lactamases

Autor:innen und Institutionen

  • UCIBIO-Applied Molecular Biosciences Unit, Laboratory of Microbiology, Department of Biological Sciences, REQUIMTE, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
  • RISE-Health, Faculty of Health Sciences, Fernando Pessoa University, 4200-150 Porto, Portugal.
  • Faculty of Health Sciences, Fernando Pessoa University, 4200-150 Porto, Portugal.

ORCID-Profile: Elisabete Machado

Zitieren

APA

Machado, E., & Sousa, J. C. (2025). New Antibiotics for Treating Infections Caused by Multidrug-Resistant Bacteria. Antibiotics, 14(10), 997. https://doi.org/10.3390/antibiotics14100997

Vancouver

Machado E, Sousa JC. New Antibiotics for Treating Infections Caused by Multidrug-Resistant Bacteria. Antibiotics. 2025;14(10):997. doi:10.3390/antibiotics14100997

BibTeX
@article{Machado2025,
  author = {Machado, Elisabete and Sousa, João Carlos},
  title = {New Antibiotics for Treating Infections Caused by Multidrug-Resistant Bacteria},
  journal = {Antibiotics},
  year = {2025},
  volume = {14},
  number = {10},
  pages = {997},
  doi = {10.3390/antibiotics14100997}
}
Kostenlos starten →